Two Sigma Securities’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,268
Closed -$225K 2683
2024
Q3
$225K Buy
+15,268
New +$239K ﹤0.01% 2037
2021
Q1
Sell
-4,317
Closed -$232K 1448
2020
Q4
$232K Buy
+4,317
New +$195K 0.01% 1267

Other funds holding NEO

Two Sigma Securities's NEO Position: Q4 2024 in Review

Two Sigma Securities sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 15,268 shares — an estimated $225K sold.

Two Sigma Securities first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $232K in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Two Sigma Securities reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 15,268 NeoGenomics shares in Q4 2024, an estimated $225K.
  • Two Sigma Securities first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
  • Two Sigma Securities's NeoGenomics position peaked at $232K in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.